Tandem high dose chemotherapy with autologous bone marrow transplantation for initial relapse of testicular germ cell cancer

Cancer

Volumn 79, Issue 8, 1997, Pages 1605-1610

  Broun, E Randolph ^a,b   Nichols, Craig R ^a   Gize, Gary ^a   Cornetta, Kenneth ^a   Hromas, Robert A ^a   Schacht, Brenda ^a   Einhorn, Lawrence H ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

autologous bone marrow transplantation; high dose chemotherapy; relapse; salvage treatment; testicular germ cell cancer

Indexed keywords

ACICLOVIR; ALPHA FETOPROTEIN; BLEOMYCIN; CARBOPLATIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; CIPROFLOXACIN; CISPLATIN; DIPHENHYDRAMINE; ETOPOSIDE; FLUCONAZOLE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; IMIPENEM; PENICILLIN G; VANCOMYCIN; VINBLASTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; DRUG MEGADOSE; FEVER; GERM CELL TUMOR; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE COUNT; MALE; NAUSEA; NEUTROPENIA; OTOTOXICITY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; REMISSION; STOMATITIS; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTE COUNT; VOMITING;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; BONE MARROW TRANSPLANTATION; CHLORAMBUCIL; CISPLATIN; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; HUMANS; IFOSFAMIDE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; REMISSION INDUCTION; SALVAGE THERAPY; TESTICULAR NEOPLASMS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; VINBLASTINE;

EID: 0030903728     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970415)79:8<1605::AID-CNCR25>3.0.CO;2-0     Document Type: Article

References (30)

1. Williams SW, Birch R, Einhorn LH, et al. Treatment of disseminated germ cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. N Engl J Med 1987;316:1435-1440.
2. Einhorn LH, Weathers T, Loehrer P, et al. Second line chemotherapy with vinblastine, ifosfamide, and cisplatin after initial chemotherapy with cisplatin, VP-16 and bleomycin (PVP16B) in disseminated germ cell tumors (GCT): long term follow-up. 1992; Proc Am Soc Clin Oncol 11:196.
3. Loehrer PJ, Lauer R, Roth BJ, et al. Salvage therapy in recurrent germ cell cancer. Ifosfamide and cisplatin plus either vinblastine or etoposide. Ann Intern Med 1988;109:540-546.
4. Motzer RJ, Cooper K, Geller NL, et al. The role of ifosfamide plus cisplatin based chemotherapy as salvage therapy for patients with refractory germ cell tumors. Cancer 1990; 66:2476-81.
5. Murphy B, Breeden E, Donohue J, et al. Surgical salvage of chemorefractory germ cell tumors. J Clin Oncol 1993; 11:324-9.
6. Nichols CR, Tricot G, Williams S, et al. Dose intensive chemotherapy in refractory germ cell cancer: a phase I/II trial of high dose carboplatin and etoposide with autologous bone marrow transplantation. J Clin Oncol 1987;7:932-9.
7. Nichols CR, Andersen J, Wolff SN, et al. High dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: an Eastern Cooperative Group Protocol.J Clin Oncol 1992;10:558-63.
8. Broun ER, Nichols CR, Kneebone P, et al. Long term outcome of patients with relapsed and refractory germ cell tumors treated with high dose chemotherapy and autologous bone marrow rescue. Ann Intern Med 1992;117:124-8.
9. Motzer RJ, Gulati SC, Crown JP, et al. High dose chemotherapy and autologous bone marrow rescue for patients with refractory germ cell tumors: earlier intervention is better tolerated. Cancer 1992;69:550-6.
10. Barnett MJ, Coppin CM, Murray N, et al. High dose chemotherapy and autologous bone marrow transplantation (BMT) for patients with poor prognosis nonseminomatous germ cell tumors. British J Cancer 1993;68:594-8.
11. Siegert W, Beyer J, Strohscheer I, et al. High dose treatment with carboplatin etoposide and ifosfamide followed by autologous stem cell transplantation in relapsed and refractory germ cell cancer: a phase I/II study. The German Testicular Cancer Cooperative Study Group. J Clin Oncol 1994; 12:1223-31.
12. Broun ER, Nichols CR, Turns M, et al. First line salvage therapy for germ cell cancer with conventional dose induction therapy followed by high dose chemotherapy with autologous bone marrow support. Cancer 1994;73:1716-20.
13. Einhorn LH, Donohue JP. Cis-diamminedichloroplatinum, vinblastine and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med 1987; 87:293-8.
14. Bosl GJ, Gluckman R, Geller NL, et al. VAB-6: an effective chemotherapy regimen for patients with germ cell tumors. J Clin Oncol 1986;4:1493-99.
15. Loehrer PJ, Einhorn LH, Williams SD. VP-16 plus ifosfamide plus cisplatin as salvage therapy in refractory germ cell cancer. J Clin Oncol 1986;4:528-36.
16. English D, Lamberson R, Graves V, et al. Semi-automated processing of bone marrow for transplantation. Transfusion 1989;29:12-16.
17. Oken MN, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649-55.
18. Motzer R, Geller N, Tan CY, et al. Salvage chemotherapy for patients with germ cell tumors: the Memorial Sloan-Kettering Cancer experience (1979-1989). Cancer 1991;67:1305-10.
19. Einhorn LH. Salvage therapy for germ cell tumors. Semin Oncol 1994;21(4 Suppl 7):47-51.
20. Motzer RJ, Gulati SC, Tong WP, et al. Phase I trial with pharmacokinetic analyses of high-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in patients with refractory germ cell tumors. Cancer Res 1993;53:3730-5.
21. Lotz JP, Andre T, Donsimoni R, et al. High dose chemotherapy with ifosfamide, carboplatin and etoposide combined with autologous bone marrow transplantation for the treatment of poor-prognosis germ cell tumors and metastatic trophoblastic disease in adults. Cancer 1995;75:874-85.
22. Broun ER, Gronin R, Kneebone P, Danielson C, Cornetta K, Cunningham I, et al. A randomized trial of the addition of peripheral blood progenitor cells (PBPC) to autologous bone marrow (ABM) in patients undergoing high dose chemotherapy with autologous progenitor support for breast and germ cell cancer (GCT). Proc Am Soc Clin Oncol 1994;13:433.
23. Beyer J, Schwella N, Zingsem J, et al. Hematopoietic rescue after high dose chemotherapy using autologous peripheral blood progenitor cells or bone marrow: a randomized comparison. J Clin Oncol 1995;13:1328-35.
24. Bosl GJ, Geller NL, Cirrinicione C, et al. Multivariate analysis of prognostic variables in patients with metastatic testicular cancer. Cancer Res 1983;3403-7.
25. Bosl GJ, Geller NL, Bajorin D. Identification and management of poor risk patients with gem cell tumors: the Memorial Sloan Kettering Cancer Center experience. Semin Oncol 1988;15:339-44.
26. Droz JP, Kramar A, Ghosn M, et al. Prognostic factors in advanced nonseminomatous testicular cancer: a multivariate logistic regression analysis. Cancer 1988;62:564-8.
27. Birch R, Williams S, Cone A, et al. Prognostic factors for favorable outcome in disseminated germ cell tumors. J Clin Oncol 1986;4:400-7.
28. Stoter G, Sylvester DT, Sleifer D, et al. Multivariate analysis of prognostic factors in patients with disseminated nonsemiomatous testicular cancer: results from a European Organization for Research on Treatment of Cancer multiinstitutional phase III study. Cancer Res 1987;47:2714-8.
29. Broun ER, Nichols CR, Einhorn, LH, Tricot GJK. Salvage therapy with high dose chemotherapy and autologous bone marrow support in the treatment of primary nonseminomatous mediastinal germ cell tumors. Cancer 1991;68(7):1513-5.
30. Saxman SB, Nichols CR, Einhorn LH. Salvage chemotherapy in patients with extragonadal nonseminomatous germ cell tumors: the Indiana University experience. J Clin Oncol 1994;12:1390-3.